363 related articles for article (PubMed ID: 35108347)
1. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
Varese A; Nakawesi J; Farias A; Kirsebom FCM; Paulsen M; Nuriev R; Johansson C
PLoS Pathog; 2022 Feb; 18(2):e1010272. PubMed ID: 35108347
[TBL] [Abstract][Full Text] [Related]
2. MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice.
Paulsen M; Varese A; Pinpathomrat N; Kirsebom FCM; Paulsen M; Johansson C
Front Immunol; 2020; 11():572747. PubMed ID: 33123150
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
Luangrath MA; Schmidt ME; Hartwig SM; Varga SM
Immunohorizons; 2021 Feb; 5(2):59-69. PubMed ID: 33536235
[TBL] [Abstract][Full Text] [Related]
4. Airway T cells protect against RSV infection in the absence of antibody.
Kinnear E; Lambert L; McDonald JU; Cheeseman HM; Caproni LJ; Tregoning JS
Mucosal Immunol; 2018 Jan; 11(1):249-256. PubMed ID: 28537249
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
Li H; Callahan C; Citron M; Wen Z; Touch S; Monslow MA; Cox KS; DiStefano DJ; Vora KA; Bett A; Espeseth A
PLoS One; 2017; 12(11):e0187642. PubMed ID: 29121080
[TBL] [Abstract][Full Text] [Related]
6. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
[TBL] [Abstract][Full Text] [Related]
7. CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.
Zhang L; Li H; Hai Y; Yin W; Li W; Zheng B; Du X; Li N; Zhang Z; Deng Y; Zeng R; Wei L
J Virol; 2017 May; 91(10):. PubMed ID: 28275186
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.
Schmidt ME; Meyerholz DK; Varga SM
Mucosal Immunol; 2020 May; 13(3):507-517. PubMed ID: 31844172
[TBL] [Abstract][Full Text] [Related]
9. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.
Jozwik A; Habibi MS; Paras A; Zhu J; Guvenel A; Dhariwal J; Almond M; Wong EHC; Sykes A; Maybeno M; Del Rosario J; Trujillo-Torralbo MB; Mallia P; Sidney J; Peters B; Kon OM; Sette A; Johnston SL; Openshaw PJ; Chiu C
Nat Commun; 2015 Dec; 6():10224. PubMed ID: 26687547
[TBL] [Abstract][Full Text] [Related]
10. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes.
Goritzka M; Makris S; Kausar F; Durant LR; Pereira C; Kumagai Y; Culley FJ; Mack M; Akira S; Johansson C
J Exp Med; 2015 May; 212(5):699-714. PubMed ID: 25897172
[TBL] [Abstract][Full Text] [Related]
11. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
[TBL] [Abstract][Full Text] [Related]
12. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
13. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.
Makris S; Bajorek M; Culley FJ; Goritzka M; Johansson C
J Innate Immun; 2016; 8(5):452-63. PubMed ID: 27423203
[TBL] [Abstract][Full Text] [Related]
14. Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
Schijf MA; Kruijsen D; Bastiaans J; Coenjaerts FE; Garssen J; van Bleek GM; van't Land B
J Virol; 2012 Nov; 86(21):11472-82. PubMed ID: 22896622
[TBL] [Abstract][Full Text] [Related]
15. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
[TBL] [Abstract][Full Text] [Related]
16. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR; Hartwig SM; Varga SM
J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
Ostler T; Ehl S
Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
[TBL] [Abstract][Full Text] [Related]
18. Role for innate IFNs in determining respiratory syncytial virus immunopathology.
Johnson TR; Mertz SE; Gitiban N; Hammond S; Legallo R; Durbin RK; Durbin JE
J Immunol; 2005 Jun; 174(11):7234-41. PubMed ID: 15905569
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil recruitment and activation are differentially dependent on MyD88/TRIF and MAVS signaling during RSV infection.
Kirsebom FCM; Kausar F; Nuriev R; Makris S; Johansson C
Mucosal Immunol; 2019 Sep; 12(5):1244-1255. PubMed ID: 31358860
[TBL] [Abstract][Full Text] [Related]
20. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
